Cortes J - Search Results

1

Azacitidine for the treatment of myelodysplastic syndrome.

Cataldo VD, Cortes J, Quintás-Cardama A. Cataldo VD, et al. Among authors: cortes j. Expert Rev Anticancer Ther. 2009 Jul;9(7):875-84. doi: 10.1586/era.09.61. Expert Rev Anticancer Ther. 2009. PMID: 19589026 Review.

2

Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia.

Quintas-Cardama A, Kantarjian H, O'Brien S, Garcia-Manero G, Rios MB, Talpaz M, Cortes J. Quintas-Cardama A, et al. Among authors: cortes j. Cancer. 2004 Jun 15;100(12):2592-7. doi: 10.1002/cncr.20285. Cancer. 2004. PMID: 15197801 Free article.

3

Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia.

Quintas-Cardama A, Kantarjian H, Talpaz M, O'Brien S, Garcia-Manero G, Verstovsek S, Rios MB, Hayes K, Glassman A, Bekele BN, Zhou X, Cortes J. Quintas-Cardama A, et al. Among authors: cortes j. Blood. 2005 Mar 15;105(6):2281-6. doi: 10.1182/blood-2004-06-2208. Epub 2004 Nov 30. Blood. 2005. PMID: 15572595 Free article. Clinical Trial.

4

Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells.

Verstovsek S, Giles FJ, Quintás-Cardama A, Manshouri T, Huynh L, Manley P, Cortes J, Tefferi A, Kantarjian H. Verstovsek S, et al. Among authors: cortes j. Leuk Res. 2006 Dec;30(12):1499-505. doi: 10.1016/j.leukres.2006.03.012. Epub 2006 May 8. Leuk Res. 2006. PMID: 16682077

5

Kinase inhibitors in chronic myelogenous leukemia.

Quintás-Cardama A, Cortes J. Quintás-Cardama A, et al. Among authors: cortes j. Clin Adv Hematol Oncol. 2006 May;4(5):365-74. Clin Adv Hematol Oncol. 2006. PMID: 16728945

6

Effects of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, on human mast cells bearing wild-type or mutated codon 816 c-kit.

Verstovsek S, Akin C, Manshouri T, Quintás-Cardama A, Huynh L, Manley P, Tefferi A, Cortes J, Giles FJ, Kantarjian H. Verstovsek S, et al. Among authors: cortes j. Leuk Res. 2006 Nov;30(11):1365-70. doi: 10.1016/j.leukres.2006.04.005. Epub 2006 Jun 23. Leuk Res. 2006. PMID: 16797704

7

Chronic myeloid leukemia: diagnosis and treatment.

Quintás-Cardama A, Cortes JE. Quintás-Cardama A, et al. Mayo Clin Proc. 2006 Jul;81(7):973-88. doi: 10.4065/81.7.973. Mayo Clin Proc. 2006. PMID: 16835977 Review.

8

EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation.

Pan J, Quintás-Cardama A, Kantarjian HM, Akin C, Manshouri T, Lamb P, Cortes JE, Tefferi A, Giles FJ, Verstovsek S. Pan J, et al. Among authors: cortes je. Blood. 2007 Jan 1;109(1):315-22. doi: 10.1182/blood-2006-04-013805. Epub 2006 Aug 15. Blood. 2007. PMID: 16912224 Free article.

9

Novel approaches in the treatment of systemic mastocytosis.

Quintas-Cardama A, Aribi A, Cortes J, Giles FJ, Kantarjian H, Verstovsek S. Quintas-Cardama A, et al. Among authors: cortes j. Cancer. 2006 Oct 1;107(7):1429-39. doi: 10.1002/cncr.22187. Cancer. 2006. PMID: 16948123 Free article. Review.

10

Advances in the therapy of chronic idiopathic myelofibrosis.

Arana-Yi C, Quintás-Cardama A, Giles F, Thomas D, Carrasco-Yalan A, Cortes J, Kantarjian H, Verstovsek S. Arana-Yi C, et al. Among authors: cortes j. Oncologist. 2006 Sep;11(8):929-43. doi: 10.1634/theoncologist.11-8-929. Oncologist. 2006. PMID: 16951397 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,761 results

Search Page